Clinical Trial Update: To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of 1146A nasal spray in adults with common cold has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• 1146A Nasal Spray

Snippet

Sponsor: GlaxoSmithKline | Conditions: Common Cold | Phase 2 | Status: COMPLETED | Results posted: 2018-06-19